首页> 外文期刊>Oral and maxillofacial surgery. >Comparison of intravenous tramadol versus ketorolac in the management of postoperative pain after oral and maxillofacial surgery
【24h】

Comparison of intravenous tramadol versus ketorolac in the management of postoperative pain after oral and maxillofacial surgery

机译:静脉曲马多与酮洛克在口腔颌面外科术后疼痛管理中的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Background The aim of this study was to assess the better postoperative analgesic, tramadol, and ketorolac, in patients with maxillofacial trauma and who had undergone maxillofacial surgery, i.e., open reduction internal fixation, under general anesthesia. Materials and methods After taking ethical approval from the institution and informed consent, 46 ASA grade I–II patients were block randomized (ABAB) based on inclusion and exclusion criteria and equally divided into two groups in which one group of patients was given intravenous tramadol 100?mg and another group of patients was given intravenous ketorolac 30?mg at the time of closure of skin and was repeated after 8 and 16?h following surgery. Pain using VAS at the 2nd, 4th, 6th, 12th, and 24th postoperative was assessed, and association of results was compared using Cramer’s V test SPSS (Version 22). Vital signs and side effects were recorded. Results Although both drugs resulted in significant decrease in pain intensity from the 2nd to 24th postoperative hour, intravenous tramadol always resulted in better pain control than intravenous ketorolac at every postoperative hour ( p value ?0.05). Conclusion Apart from first 2?h where the changes are non-significant, this study clearly demonstrates the advantage of the intravenous tramadol in the management of postoperative pain and ease of administration in postoperative patient through IV cannula. The side effects of both the drugs were insignificant and did not have any effect on the result.
机译:背景技术本研究的目的是评估颌面外伤的患者术后镇痛,曲马多和酮洛克,并且在全身麻醉下,颌面外科,即开放式内部固定。从机构和知情同意采取道德批准后的材料和方法,基于包含和排除标准,46级I-II患者被嵌段嵌段(ABAB),并将一组患者静脉曲折的曲马多(静脉曲马多?Mg和另一组患者在闭合皮肤时静脉内酮咯克30μmg,并在术后8和16μl后重复。评估使用VAS的VAS疼痛评估,使用CRAMER的V TEST SPSS(版本22)进行比较结果。记录生命的迹象和副作用。结果虽然两种药物导致术后第2小时的疼痛强度显着降低,但静脉曲马多总导致每个术后小时的静脉内酮咯酸均导致更好的疼痛控制(P值?0.05)。结论除了第2次吗?其中的变化是非显着的,本研究清楚地证明了静脉内曲马多在术后患者术后患者术后疼痛和易于给药的优势。两种药物的副作用是微不足道的,对结果没有任何影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号